199 related articles for article (PubMed ID: 24751304)
1. Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial.
Bobo WV; Reilly-Harrington NA; Ketter TA; Brody BD; Kinrys G; Kemp DE; Shelton RC; McElroy SL; Sylvia LG; Kocsis JH; McInnis MG; Friedman ES; Singh V; Tohen M; Bowden CL; Deckersbach T; Calabrese JR; Thase ME; Nierenberg AA; Rabideau DJ; Schoenfeld DA; Faraone SV; Kamali M
J Affect Disord; 2014 Jun; 161():30-5. PubMed ID: 24751304
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder.
Nierenberg AA; Sylvia LG; Leon AC; Reilly-Harrington NA; Shesler LW; McElroy SL; Friedman ES; Thase ME; Shelton RC; Bowden CL; Tohen M; Singh V; Deckersbach T; Ketter TA; Kocsis JH; McInnis MG; Schoenfeld D; Bobo WV; Calabrese JR;
Clin Trials; 2014 Feb; 11(1):114-27. PubMed ID: 24346608
[TBL] [Abstract][Full Text] [Related]
3. The ARIQUELI study: potentiation of quetiapine in bipolar I nonresponders with lithium versus aripiprazole.
Missio G; Moreno DH; Fernandes F; Bio DS; Soeiro-de-Souza MG; Rodrigues dos Santos D; David DP; Costa LF; Demétrio FN; Moreno RA
Trials; 2013 Jun; 14():190. PubMed ID: 23805994
[TBL] [Abstract][Full Text] [Related]
4. Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder.
Nierenberg AA; McElroy SL; Friedman ES; Ketter TA; Shelton RC; Deckersbach T; McInnis MG; Bowden CL; Tohen M; Kocsis JH; Calabrese JR; Kinrys G; Bobo WV; Singh V; Kamali M; Kemp D; Brody B; Reilly-Harrington NA; Sylvia LG; Shesler LW; Bernstein EE; Schoenfeld D; Rabideau DJ; Leon AC; Faraone S; Thase ME
J Clin Psychiatry; 2016 Jan; 77(1):90-9. PubMed ID: 26845264
[TBL] [Abstract][Full Text] [Related]
5. A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first episode mania: A 12-month follow-up study.
Daglas R; Cotton SM; Allott K; Yücel M; Macneil CA; Hasty MK; Murphy B; Pantelis C; Hallam KT; Henry LP; Conus P; Ratheesh A; Kader L; Wong MT; McGorry PD; Berk M
Eur Psychiatry; 2016 Jan; 31():20-8. PubMed ID: 26655594
[TBL] [Abstract][Full Text] [Related]
6. Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression.
Kim SJ; Lee YJ; Lee YJ; Cho SJ
J Affect Disord; 2014 Mar; 157():33-40. PubMed ID: 24581825
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: results of a Markov model analysis.
Fajutrao L; Paulsson B; Liu S; Locklear J
Clin Ther; 2009 Jun; 31 Pt 1():1456-68. PubMed ID: 19698903
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
Woodward TC; Tafesse E; Quon P; Lazarus A
Pharmacoeconomics; 2010; 28(9):751-64. PubMed ID: 20623994
[TBL] [Abstract][Full Text] [Related]
9. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
[TBL] [Abstract][Full Text] [Related]
10. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
Jing Y; Kim E; You M; Pikalov A; Tran QV
J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network.
Suppes T; Kelly DI; Keck PE; McElroy SL; Altshuler LL; Mintz J; Frye MA; Nolen WA; Luckenbaugh DA; Post RM; Leverich GS; Kupka RW; Grunze H
Int Clin Psychopharmacol; 2007 Nov; 22(6):376-81. PubMed ID: 17917557
[TBL] [Abstract][Full Text] [Related]
12. Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study.
Li H; Ma C; Wang G; Zhu X; Peng M; Gu N
Curr Med Res Opin; 2008 Jan; 24(1):1-10. PubMed ID: 18028587
[TBL] [Abstract][Full Text] [Related]
13. Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithium.
Ketter TA; Miller S; Dell'Osso B; Wang PW
J Affect Disord; 2016 Feb; 191():256-73. PubMed ID: 26688495
[TBL] [Abstract][Full Text] [Related]
14. Complexity of illness and adjunctive benzodiazepine use in outpatients with bipolar I or II disorder: results from the Bipolar CHOICE study.
Bobo WV; Reilly-Harrington NA; Ketter TA; Brody BD; Kinrys G; Kemp DE; Shelton RC; McElroy SL; Sylvia LG; Kocsis JH; McInnis MG; Friedman ES; Singh V; Tohen M; Bowden CL; Deckersbach T; Calabrese JR; Thase ME; Nierenberg AA; Rabideau DJ; Schoenfeld DA; Faraone SV; Kamali M
J Clin Psychopharmacol; 2015 Feb; 35(1):68-74. PubMed ID: 25514063
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate.
Sokolski KN; Denson TF
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):863-6. PubMed ID: 12921920
[TBL] [Abstract][Full Text] [Related]
16. Sequential Multiple Assignment Randomized Treatment (SMART) for Bipolar Disorder at Any Phase of Illness and at least Mild Symptom Severity.
Gao K; Arnold JG; Prihoda TJ; Quinones M; Singh V; Schinagle M; Conroy C; D'Arcangelo N; Bai Y; Calabrese JR; Bowden CL
Psychopharmacol Bull; 2020 May; 50(2):8-25. PubMed ID: 32508363
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.
Bowden CL; Grunze H; Mullen J; Brecher M; Paulsson B; Jones M; Vågerö M; Svensson K
J Clin Psychiatry; 2005 Jan; 66(1):111-21. PubMed ID: 15669897
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes of acute bipolar depressive episode with psychosis.
Caldieraro MA; Dufour S; Sylvia LG; Gao K; Ketter TA; Bobo WV; Walsh S; Janos J; Tohen M; Reilly-Harrington NA; McElroy SL; Shelton RC; Bowden CL; Deckersbach T; Nierenberg AA
Depress Anxiety; 2018 May; 35(5):402-410. PubMed ID: 29329498
[TBL] [Abstract][Full Text] [Related]
19. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
McIntyre RS; Konarski JZ; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol do not affect 6-month mood-stabilizing treatment outcome among 482 patients with bipolar disorder.
Köhler-Forsberg O; Sylvia L; Thase M; Calabrese JR; Deckersbach T; Tohen M; Bowden CL; McInnis M; Kocsis JH; Friedman ES; Ketter TA; McElroy S; Shelton RC; Nierenberg AA
Depress Anxiety; 2017 Mar; 34(3):281-290. PubMed ID: 28135023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
